A bill to create a limited population pathway for approval of certain antibacterial drugs.
The bill’s titles are written by its sponsor.
Jan 16, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on April 6, 2016, in a previous session of Congress, but was not enacted.
Senior Senator from Utah
Read Text »
Last Updated: Apr 18, 2016
Length: 18 pages
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
S. 185 (114th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2017). S. 185 — 114th Congress: PATH Act. Retrieved from https://www.govtrack.us/congress/bills/114/s185
“S. 185 — 114th Congress: PATH Act.” www.GovTrack.us. 2015. June 25, 2017 <https://www.govtrack.us/congress/bills/114/s185>
|title=S. 185 (114th)
|accessdate=June 25, 2017
|author=114th Congress (2015)
|date=January 16, 2015